Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - capsule, modified release - excipient ingredients: sucrose; gelatin; methacrylic acid copolymer; purified talc; purified water; ethylcellulose; diethyl phthalate; maize starch; hypromellose; macrogol 6000 - for the prolonged relief of chronic, moderate to severe pain in patients requiring repeated dosing with potent opioid analgesics over a period of more than a few days.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - morphine sulfate pentahydrate, quantity: 20 mg - capsule, modified release - excipient ingredients: sucrose; maize starch; macrogol 6000; ethylcellulose; gelatin; methacrylic acid copolymer; purified water; purified talc; diethyl phthalate; hypromellose - for the prolonged relief of chronic, moderate to severe pain in patients requiring repeated dosing with potent opioid analgesics over a period of more than a few days.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - morphine sulfate pentahydrate, quantity: 20 mg - capsule, modified release - excipient ingredients: purified talc; gelatin; sucrose; hypromellose; ethylcellulose; macrogol 6000; methacrylic acid copolymer; maize starch; purified water; diethyl phthalate - for the prolonged relief of chronic, moderate to severe pain in patients requiring repeated dosing with potent opioid analgesics over a period of more than a few days.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - morphine sulfate pentahydrate, quantity: 50 mg - capsule, modified release - excipient ingredients: purified water; gelatin; sucrose; methacrylic acid copolymer; diethyl phthalate; ethylcellulose; purified talc; hypromellose; maize starch; macrogol 6000 - for the prolonged relief of chronic, moderate to severe pain in patients requiring repeated dosing with potent opioid analgesics over a period of more than a few days.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - capsule, modified release - excipient ingredients: hypromellose; maize starch; diethyl phthalate; purified talc; purified water; ethylcellulose; sucrose; macrogol 6000; methacrylic acid copolymer; gelatin - for the prolonged relief of chronic, moderate to severe pain in patients requiring repeated dosing with potent opioid analgesics over a period of more than a few days.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - aspirin, quantity: 100 mg - capsule, enteric - excipient ingredients: purified water; hypromellose phthalate; wheat starch; magnesium stearate; gelatin; hyprolose; diethyl phthalate; microcrystalline cellulose - prophylaxis and treatment of transient ischaemic attacks (tia) and other thromboembolic disorders for inhibition of platelet aggregation. astrix 100, used in conjunction with anticoagulant therapy, is indicated to reduce the risk of systemic embolism or vascular death in post-surgical patients who have undergone heart valve replacement.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - aspirin, quantity: 826 mg/g - capsule, modified release - excipient ingredients: purified water; hyprolose; diethyl phthalate; microcrystalline cellulose; magnesium stearate; hypromellose phthalate; wheat starch - export astrix 100,used in conjunction with anticoagulant therapy, is indicated to reduce the risk of systemic embolism or vascular death in post-surgical patients who have undergone heart valve replacement.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - itraconazole, quantity: 65 mg - capsule - excipient ingredients: hypromellose phthalate; sodium starch glycollate type a; magnesium stearate; silicon dioxide; gelatin; titanium dioxide; brilliant blue fcf; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - ? tolsura is a triazole indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients (1): o blastomycosis, pulmonary and extrapulmonary o histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and o aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin b therapy.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - levodopa, quantity: 250 mg; carbidopa, quantity: 25 mg - tablet - excipient ingredients: pregelatinised maize starch; indigo carmine aluminium lake; maize starch; microcrystalline cellulose; magnesium stearate; purified water - carbidopa and levodopa tablets usp are indicated in the treatment of parkinson's disease post encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication and manganese intoxication.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - levodopa, quantity: 100 mg; carbidopa, quantity: 25 mg - tablet - excipient ingredients: pregelatinised maize starch; quinoline yellow aluminium lake; sunset yellow fcf aluminium lake; microcrystalline cellulose; magnesium stearate; purified water; maize starch - carbidopa and levodopa tablets usp are indicated in the treatment of parkinson's disease post encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication and manganese intoxication.